Meet the Team
Dr. Samah Loutfy
Professor
​ Ext: 7
-
Education History:
1. B.Sc. Microbiology& Chemistry, 1987(May).
(Excellent with Honor Degree).
Ain Shams University.
2. M.Sc. Microbiology, 1993 (June)
(The Susceptibility to Measles Virus Infection
Among Pediatric Acute Lymphoblastic Leukemias
at the National Cancer Institute in Egypt).
Ain Shams University.
3. Ph.D. Virology & Immunology , 2001(May)
(Cytomegalovirus infection in imunocompromised
Cancer patients Immunovirological study) at the National Cancer Institute-Cairo University.
​
-
Bio:
-
and Immunology at Cancer Biology Dept., National Cancer Institute, Cairo University In Egypt since 1988 till now. Spent subsequent years (1995-1997) at Kuwait health laboratories, Virology section from 2003-2006 in clinical virology at WHO Collaborating Center for Acquired Immunodeficiency Syndrome (AIDS), and WHO Collaborating Center for Virus Reference and Research for the Eastern Mediterranean Region (EMR), Virology Unit, Microbiology Department, Faculty of Medicine, Kuwait University. She has been complied with certification and accreditation standards, sharing in internal and external proficiency program with UK. Clinical attachment at National laser research institute, Cairo University from Jan 2010 till Jan 2012. From Feb 2019 till now at Nanotechnology Research Center, BUE, Egypt. Member of Egyptian Society of virology, Egyptian society of Immunology. Member of American society of virology and Pan American society of clinical virology. Reviewer at clinical virology journal. She has been awarded for the best clinical research in 2005 and 2006 from Kuwait University. Awarded for international publications from Cairo University yearly since 2010. Best poster award, National Cancer institute, Cairo University BGO 2016&2017.
Links: 1) Research Gate/ Google Scholar Profile’s Link/s:
-
Orchid ID: 0000-0001-5711-2079
Fields of Interest: -
-
Nanoparticles as a delivery system for anticancers and antiviral agents as a promising tool for treatment of cancers and infectious diseases
-
- Establishment diagnostic tools for viral infections in patients with human cancers (hematological malignancies), investigating its negative impact on pathogenesis and outcome of the disease.
- Laboratory accreditation and application of 6 sigma in healthcare work field
-Screening tools for anticancers and antimicrobial activities, and economic tools for detecting tumor suppressor genes and evaluating associated risk factors (genomic & environmental). -
Projects Supervised: Multiplex PCR for detection of respiratory viruses in patients with Lower respiratory tract
infections in Kuwait, Kuwait University, 2004.
-Chemotherapeutic Nano-Engineering: New Route to Decrease the Side Effects of
Chemotherapy accepted on 27/10/09. Lazer Institute, Cairo University.
- Multiplex PCR for Direct Diagnosis of 6 Major Human Herpes Viruses Infections
in Pediatric Cancer Patients at the National Cancer Institute in Egypt, National
Cancer Institute, Cairo University, accepted October, 2011.
- In-Vitro Effect of Metallic Nanoparticles versus Polymeric Nanoparticles on
Proliferation of Human Cancer Cells. (Funded by ASRT, New Generation of Scientists, 2015-
- Establishment and standardization of a test for the efficiency of current and newly
emerging anti-HCV Genotype 4 agents. (Accepted STDF, No.15108)
May 2015.
- Joining 44 Research Project “Molecular Modelling study of matrix protein VP40
from Ebola virus: Discovery of new inhibitors involving virtual screening,
molecular docking&ADMET study” May 2015. In collaboration with
Biodiscovery group.
- BRCA1 and BRCA2 genes mutations and associated Mouse Mammary tumor
virus as risk factors in Familial and Non Familial Breast Cancer at National
Cancer Institute, Cairo University. (Under Review STDF, No.22944) Sept 2017.
- Immune Status of Pediatric Patients with hematologic malignancies against Measles, Varicella Zoster, and Hepatitis B virus; Molecular and clinical relevance (STDF 22948, 23 Jan 2018)
​
​
​
​
​
​
​
​
​
​
​
​
​
​